Immune checkpoint inhibitors: a new frontier in bladder cancer

被引：15
|
作者：
Kates, Max [1 ,2 ]
Sopko, Nikolai A. [1 ,2 ]
Matsui, Hotaka [1 ,2 ]
Drake, Charles G. [1 ,2 ]
Hahn, Noah M. [1 ,2 ]
Bivalacqua, Trinity J. [1 ,2 ]
机构：
[1] Johns Hopkins Sch Med, James Buchanan Brady Urol Inst, 1800 Orleans St,Marburg 420, Baltimore, MD 21287 USA
[2] Johns Hopkins Sch Med, Dept Urol, 1800 Orleans St,Marburg 420, Baltimore, MD 21287 USA
来源：
WORLD JOURNAL OF UROLOGY | 2016年 / 34卷 / 01期
基金：
美国国家卫生研究院;
关键词：
Immune checkpoint; Bladder cancer; Tumor immunology; BACILLUS-CALMETTE-GUERIN; PD-1; BLOCKADE; UROTHELIAL CARCINOMA; ANTI-PD-L1; ANTIBODY; ANTITUMOR IMMUNITY; ADVANCED MELANOMA; IFN-GAMMA; CTLA-4; EXPRESSION; SAFETY;
D O I：
10.1007/s00345-015-1709-y
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Immunotherapy is rapidly changing the field of urologic oncology. In this review, we discuss the role of the immune system in general and place a particular emphasis on the biology of the immune checkpoint and its role in cancer. Bladder cancer, as one of the most immunogenic neoplasms, is an exciting target for immune checkpoint inhibition. Early preclinical data and human trial experience suggest that this new drug class may shape bladder cancer therapy for years to come.
引用
收藏
页码：49 / 55
页数：7
相关论文
共 50 条
  • [41] Immune checkpoint inhibitors in penile cancer
    Buonerba, Carlo
    Scafuri, Luca
    Costabile, Ferdinando
    D'Ambrosio, Bruno
    Gatani, Simona
    Verolino, Pasquale
    Di Trolio, Rossella
    Cosimato, Vincenzo
    Verde, Antonio
    Di Lorenzo, Giuseppe
    [J]. FUTURE SCIENCE OA, 2021, 7 (07):
  • [42] Immune checkpoint inhibitors for the treatment of cancer
    Haanen, John B. A. G.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 7 - 7
  • [43] Immune checkpoint inhibitors in endometrial cancer
    Gomez-Raposo, C.
    Salvador, M. Merino
    Zamora, C. Aguayo
    de Santiago, B. Garcia
    Saenz, E. Casado
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 161
  • [44] Immune Checkpoint Inhibitors in the Treatment of Cancer
    Zam, Wissam
    Ali, Lina
    [J]. CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2022, 17 (02) : 103 - 113
  • [45] Immune Checkpoint Inhibitors in Prostate Cancer
    Venkatachalam, Shobi
    McFarland, Taylor R.
    Agarwal, Neeraj
    Swami, Umang
    [J]. CANCERS, 2021, 13 (09)
  • [46] Immune Checkpoint Inhibitors in Cancer Therapy
    Shiravand, Yavar
    Khodadadi, Faezeh
    Kashani, Seyyed Mohammad Amin
    Hosseini-Fard, Seyed Reza
    Hosseini, Shadi
    Sadeghirad, Habib
    Ladwa, Rahul
    O'Byrne, Ken
    Kulasinghe, Arutha
    [J]. CURRENT ONCOLOGY, 2022, 29 (05) : 3044 - 3060
  • [47] Immune checkpoint inhibitors for cancer treatment
    Junsik Park
    Minsuk Kwon
    Eui-Cheol Shin
    [J]. Archives of Pharmacal Research, 2016, 39 : 1577 - 1587
  • [48] Bladder Cancer Exhibiting High Immune Infiltration Shows the Lowest Response Rate to Immune Checkpoint Inhibitors
    Pan, Shen
    Zhan, Yunhong
    Chen, Xiaonan
    Wu, Bin
    Liu, Bitian
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [49] Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope
    Morales-Barrera, Rafael
    Suarez, Cristina
    Martinez de Castro, Ana
    Racca, Fabricio
    Valverde, Claudia
    Maldonado, Xavier
    Maria Bastaros, Juan
    Morote, Juan
    Carles, Joan
    [J]. CANCER TREATMENT REVIEWS, 2016, 50 : 208 - 216
  • [50] Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer
    Long, Qilai
    Ma, Ai-Hong
    Zhang, Hongyong
    Cao, Zhixiu
    Xia, Roger
    Lin, Tzu-Yin
    Sonpavde, Guru P.
    White, Ralph de Vere
    Guo, Jianming
    Pan, Chong-Xian
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (11) : 2305 - 2317
12345